Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 77

1.

Preoperative GNAS and KRAS Testing in the Diagnosis of Pancreatic Mucinous Cysts.

Singhi AD, Nikiforova MN, Fasanella KE, McGrath KM, Pai RK, Ohori NP, Bartholow TL, Brand RE, Chennat JS, Lu X, Papachristou GI, Slivka A, Zeh HJ, Zureikat AH, Lee KK, Tsung A, Mantha GS, Khalid A.

Clin Cancer Res. 2014 Jun 17. [Epub ahead of print]

PMID:
24938521
[PubMed - as supplied by publisher]
2.

A clinical algorithm for fine-needle aspiration molecular testing effectively guides the appropriate extent of initial thyroidectomy.

Yip L, Wharry LI, Armstrong MJ, Silbermann A, McCoy KL, Stang MT, Ohori NP, LeBeau SO, Coyne C, Nikiforova MN, Bauman JE, Johnson JT, Tublin ME, Hodak SP, Nikiforov YE, Carty SE.

Ann Surg. 2014 Jul;260(1):163-8. doi: 10.1097/SLA.0000000000000215.

PMID:
24901361
[PubMed - in process]
3.

PAX8/PPARγ Rearrangement in Thyroid Nodules Predicts Follicular-Pattern Carcinomas, in Particular the Encapsulated Follicular Variant of Papillary Carcinoma.

Armstrong MJ, Yang H, Yip L, Ohori NP, McCoy KL, Stang MT, Hodak SP, Nikiforova MN, Carty SE, Nikiforov YE.

Thyroid. 2014 Jul 16. [Epub ahead of print]

PMID:
24798894
[PubMed - as supplied by publisher]
4.

Thyroid nodules (≥4 cm): can ultrasound and cytology reliably exclude cancer?

Wharry LI, McCoy KL, Stang MT, Armstrong MJ, LeBeau SO, Tublin ME, Sholosh B, Silbermann A, Ohori NP, Nikiforov YE, Hodak SP, Carty SE, Yip L.

World J Surg. 2014 Mar;38(3):614-21. doi: 10.1007/s00268-013-2261-9.

PMID:
24081539
[PubMed - in process]
5.

Nodule size is an independent predictor of malignancy in mutation-negative nodules with follicular lesion of undetermined significance cytology.

Mehta RS, Carty SE, Ohori NP, Hodak SP, Coyne C, LeBeau SO, Tublin ME, Stang MT, Johnson JT, McCoy KL, Nikiforova MN, Nikiforov YE, Yip L.

Surgery. 2013 Oct;154(4):730-6; discussion 736-8. doi: 10.1016/j.surg.2013.05.015.

PMID:
24074409
[PubMed - indexed for MEDLINE]
6.

From headache to heartache: ergotamine-induced aortic and mitral valvulopathy.

Patel SM, Ohori NP, Badhwar V, Cavalcante JL.

J Am Coll Cardiol. 2013 Dec 3;62(22):2144. doi: 10.1016/j.jacc.2013.06.065. Epub 2013 Sep 22. No abstract available.

PMID:
24067402
[PubMed - indexed for MEDLINE]
7.

Correlation of ultrasound findings with the Bethesda cytopathology classification for thyroid nodule fine-needle aspiration: a primer for radiologists.

Heller MT, Gilbert C, Ohori NP, Tublin ME.

AJR Am J Roentgenol. 2013 Sep;201(3):W487-94. doi: 10.2214/AJR.12.9071. Review.

PMID:
23971481
[PubMed - indexed for MEDLINE]
8.

"Colloid-rich" follicular neoplasm/suspicious for follicular neoplasm thyroid fine-needle aspiration specimens: cytologic, histologic, and molecular basis for considering an alternate view.

Ohori NP, Wolfe J, Hodak SP, LeBeau SO, Yip L, Carty SE, Duvvuri U, Schoedel KE, Nikiforova MN, Nikiforov YE.

Cancer Cytopathol. 2013 Dec;121(12):718-28. doi: 10.1002/cncy.21333. Epub 2013 Jul 23.

PMID:
23881852
[PubMed - indexed for MEDLINE]
9.

Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts.

Nikiforova MN, Khalid A, Fasanella KE, McGrath KM, Brand RE, Chennat JS, Slivka A, Zeh HJ, Zureikat AH, Krasinskas AM, Ohori NP, Schoedel KE, Navina S, Mantha GS, Pai RK, Singhi AD.

Mod Pathol. 2013 Nov;26(11):1478-87. doi: 10.1038/modpathol.2013.91. Epub 2013 Jun 7.

PMID:
23743931
[PubMed - indexed for MEDLINE]
10.

RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancers.

Gupta N, Dasyam AK, Carty SE, Nikiforova MN, Ohori NP, Armstrong M, Yip L, LeBeau SO, McCoy KL, Coyne C, Stang MT, Johnson J, Ferris RL, Seethala R, Nikiforov YE, Hodak SP.

J Clin Endocrinol Metab. 2013 May;98(5):E914-22. doi: 10.1210/jc.2012-3396. Epub 2013 Mar 28.

PMID:
23539734
[PubMed - indexed for MEDLINE]
11.

BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.

Ohori NP, Singhal R, Nikiforova MN, Yip L, Schoedel KE, Coyne C, McCoy KL, LeBeau SO, Hodak SP, Carty SE, Nikiforov YE.

Cancer Cytopathol. 2013 Apr;121(4):197-205. doi: 10.1002/cncy.21229. Epub 2012 Aug 7.

PMID:
22887810
[PubMed - indexed for MEDLINE]
12.

Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancer.

McCoy KL, Carty SE, Armstrong MJ, Seethala RR, Ohori NP, Kabaker AS, Stang MT, Hodak SP, Nikiforov YE, Yip L.

J Am Coll Surg. 2012 Oct;215(4):546-54. doi: 10.1016/j.jamcollsurg.2012.05.027. Epub 2012 Jul 4.

PMID:
22766226
[PubMed - indexed for MEDLINE]
13.

Orbital metastasis as the initial presentation of invasive lobular carcinoma of breast.

Tomizawa Y, Ocque R, Ohori NP.

Intern Med. 2012;51(12):1635-8. Epub 2012 Jun 15.

PMID:
22728506
[PubMed - indexed for MEDLINE]
Free Article
14.

Variability in the atypia of undetermined significance/follicular lesion of undetermined significance diagnosis in the Bethesda System for Reporting Thyroid Cytopathology: sources and recommendations.

Ohori NP, Schoedel KE.

Acta Cytol. 2011;55(6):492-8. doi: 10.1159/000334218. Epub 2011 Dec 9. Review.

PMID:
22156456
[PubMed - indexed for MEDLINE]
15.

EUS-FNA mutational analysis in differentiating autoimmune pancreatitis and pancreatic cancer.

Khalid A, Dewitt J, Ohori NP, Chen JH, Fasanella KE, Sanders M, McGrath KM, Nikiforova M.

Pancreatology. 2011;11(5):482-6. doi: 10.1159/000331505. Epub 2011 Oct 11.

PMID:
21997479
[PubMed - indexed for MEDLINE]
16.

Selective screening for nongynecologic cytology specimens: modifying the screening process for improved efficiency and practice.

Marks-Jones DA, Sutkowski BA, Schoedel KE, Ohori NP.

Diagn Cytopathol. 2011 Oct;39(10):717-22. doi: 10.1002/dc.21449. Epub 2010 Nov 2.

PMID:
21919214
[PubMed - indexed for MEDLINE]
17.

Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples.

Nikiforov YE, Ohori NP, Hodak SP, Carty SE, LeBeau SO, Ferris RL, Yip L, Seethala RR, Tublin ME, Stang MT, Coyne C, Johnson JT, Stewart AF, Nikiforova MN.

J Clin Endocrinol Metab. 2011 Nov;96(11):3390-7. doi: 10.1210/jc.2011-1469. Epub 2011 Aug 31.

PMID:
21880806
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Usefulness of immunohistochemical and histochemical studies in the classification of lung adenocarcinoma and squamous cell carcinoma in cytologic specimens.

Ocque R, Tochigi N, Ohori NP, Dacic S.

Am J Clin Pathol. 2011 Jul;136(1):81-7. doi: 10.1309/AJCPFKOLGL6PMOF3.

PMID:
21685035
[PubMed - indexed for MEDLINE]
Free Article
19.

Thyroid cytology: challenges in the pursuit of low-grade malignancies.

Ohori NP, Schoedel KE.

Radiol Clin North Am. 2011 May;49(3):435-51, v-vi. doi: 10.1016/j.rcl.2011.02.005. Review.

PMID:
21569903
[PubMed - indexed for MEDLINE]
20.

Bronchoscopic and transthoracic cytology and biopsy for pulmonary nonsmall cell carcinomas: performance characteristics by procedure and tumor type.

Tochigi N, Dacic S, Ohori NP.

Diagn Cytopathol. 2012 Aug;40(8):659-63. doi: 10.1002/dc.21588. Epub 2011 Feb 13.

PMID:
21319328
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk